Can I Take L-Theanine with Crestor (Rosuvastatin)?

What Is Rosuvastatin and How Does It Work?

Rosuvastatin is a synthetic, hydrophilic HMG-CoA reductase inhibitor approved by the FDA in August 2003 for adults with primary hyperlipidemia, mixed dyslipidemia, and cardiovascular risk reduction. It lowers LDL-C by blocking the rate-limiting step in hepatic cholesterol synthesis, which upregulates LDL receptors and accelerates clearance of circulating LDL particles from the blood.

Pharmacokinetic Profile

Rosuvastatin is absorbed primarily in the liver via organic anion transporting polypeptides OATP1B1 and OATP1B3. Its systemic bioavailability is only about 20%, and roughly 90% of the absorbed dose is eliminated unchanged in feces. CYP2C9 accounts for a minor fraction of hepatic metabolism. CYP3A4, the enzyme responsible for metabolizing most statin-supplement interactions involving atorvastatin or simvastatin, plays virtually no role in rosuvastatin clearance. [1]

This narrow metabolic footprint is why rosuvastatin carries a shorter interaction list than lipophilic statins like simvastatin.

Clinical Efficacy Data

In the JUPITER trial (N=17,802), rosuvastatin 20 mg reduced LDL-C by 50% and cut the primary composite cardiovascular endpoint by 44% compared with placebo over a median of 1.9 years (hazard ratio 0.56, 95% CI 0.46 to 0.69, P<0.001). [2] That magnitude of LDL reduction depends on consistent drug exposure, which is one reason any supplement capable of altering rosuvastatin bioavailability warrants scrutiny.

What Is L-Theanine?

L-theanine (gamma-glutamylethylamide) is a non-protein amino acid found almost exclusively in tea leaves of Camellia sinensis. It is sold as a stand-alone supplement, typically in 100 to 200 mg capsules, and is heavily marketed for stress relief and cognitive calm, often paired with caffeine.

Mechanism of Action

L-theanine crosses the blood-brain barrier and modulates several neurotransmitter systems. It increases alpha-wave activity on EEG, raises brain GABA, dopamine, and serotonin levels, and attenuates the sympathomimetic effects of caffeine without causing sedation. [3] None of these central mechanisms overlap with rosuvastatin's hepatic cholesterol-synthesis target.

How the Body Processes It

After oral ingestion, L-theanine is hydrolyzed in the small intestine brush-border epithelium to ethylamine and L-glutamate. Peak plasma concentration occurs at roughly 50 minutes post-dose. It is not a substrate, inhibitor, or inducer of CYP1A2, CYP2C9, CYP2C19, CYP2D6, or CYP3A4 at doses used in humans. [4] It does not appear to modulate OATP1B1 or OATP1B3 activity based on current in vitro data.

Is There a Pharmacokinetic Interaction Between L-Theanine and Rosuvastatin?

No pharmacokinetic interaction between L-theanine and rosuvastatin has been reported in any published clinical trial, pharmacokinetic study, or drug-interaction database as of early 2025.

CYP450 Enzyme Overlap

The most common mechanism behind clinically meaningful statin interactions is inhibition of CYP3A4 (grapefruit juice, azole antifungals, macrolide antibiotics). Rosuvastatin largely bypasses CYP3A4, and L-theanine does not inhibit or induce any CYP450 isoform known to process the small CYP2C9-mediated fraction of rosuvastatin. [1][4]

Transporter Overlap

Rosuvastatin's hepatic uptake depends heavily on OATP1B1 and OATP1B3. Strong inhibitors of these transporters, such as cyclosporine or gemfibrozil, can dramatically raise rosuvastatin plasma concentrations and increase myopathy risk. No published data suggest that L-theanine, at any dose studied in humans, inhibits these transporters. [5]

P-Glycoprotein

L-theanine does not appear to meaningfully inhibit P-glycoprotein in human cell-line models. Rosuvastatin is a minor P-gp substrate, but even confirmed P-gp inhibitors produce only modest changes in rosuvastatin exposure, so this pathway is unlikely to be clinically significant for the combination. [1]

Is There a Pharmacodynamic Interaction?

A pharmacodynamic interaction occurs when two agents affect the same physiological target, amplifying or opposing each other's effects. L-theanine and rosuvastatin do not share a pharmacodynamic target.

Cardiovascular Pathways

Rosuvastatin acts exclusively on HMG-CoA reductase in the liver. L-theanine's cardiovascular data are limited, but a 2012 parallel-arm RCT (N=91) found that 200 mg L-theanine twice daily for 16 weeks produced no statistically significant change in fasting lipid panels compared with placebo. [6] There is no evidence that L-theanine adds to, or subtracts from, the LDL-lowering effect of a statin.

Muscle and Hepatic Safety

Statin-associated muscle symptoms (SAMS) occur in 5 to 10% of statin users and are the most common reason for discontinuation. The mechanisms involve mitochondrial dysfunction, reduced CoQ10 synthesis, and impaired myocyte membrane integrity. L-theanine has no known interaction with mitochondrial electron transport or CoQ10 pathways. [7] No case series or pharmacovigilance signal links L-theanine supplementation to worsened SAMS.

Rosuvastatin carries a small risk of transaminase elevation (less than 1% of users in clinical trials). L-theanine at doses up to 900 mg/day for 8 weeks showed no hepatotoxic signal in the only published safety study to measure liver enzymes directly. [4] The combination does not appear to create additive hepatotoxic risk.

Blood Pressure and Heart Rate

Rosuvastatin has a modest pleiotropic effect on endothelial nitric oxide production. L-theanine may reduce resting blood pressure slightly in high-stress individuals, with a 2012 study (N=14) documenting a mean systolic reduction of 2.5 mmHg. [3] This magnitude is unlikely to cause clinically significant hypotension in combination with a statin.

What the Drug-Interaction Databases Say

Three widely used clinical interaction databases, Natural Medicines, Lexicomp, and Drugs.com, do not list a rosuvastatin-L-theanine interaction as of early 2025. The Natural Medicines Comprehensive Database rates L-theanine as having "no known interactions" with HMG-CoA reductase inhibitors.

The framework below organizes how clinicians at HealthRX evaluate supplement-statin combinations, using L-theanine as an example. A supplement earns a "caution" flag if it meets at least one of three criteria: (1) it inhibits or induces an enzyme or transporter that handles the statin, (2) it shares an end-organ toxicity target (muscle, liver), or (3) controlled trial data show a lipid or safety outcome change. L-theanine meets none of these three criteria with rosuvastatin.

Who Might Still Want to Exercise Caution?

Most adults on rosuvastatin can take standard L-theanine doses without special precautions. Certain sub-groups warrant a brief check-in with their prescriber before adding the supplement.

People Taking High-Dose Rosuvastatin

The FDA label for rosuvastatin 40 mg notes a higher myopathy risk than lower doses. [1] Anyone on 40 mg is already at the ceiling of the dose range, and adding any new supplement, even one without a known mechanism of harm, is worth discussing with the prescribing clinician simply to document the decision.

People with Pre-Existing Liver Disease

Both rosuvastatin and very high-dose L-theanine (above the studied 900 mg/day range) lack strong safety data in patients with active hepatic disease. If baseline transaminases are already elevated above three times the upper limit of normal, the prescriber will typically pause statins anyway, but L-theanine's hepatic safety data are also thin in this population.

People Combining L-Theanine with Caffeine Products

L-theanine is commonly sold in combination with caffeine. Caffeine itself is a substrate of CYP1A2 and, at very high doses, may have minor hemodynamic effects. Rosuvastatin does not interact with CYP1A2, so co-ingestion of a caffeine-theanine product with rosuvastatin is not expected to be problematic. Still, large quantities of caffeine (above 400 mg/day) can raise blood pressure, which is counterproductive in patients managing cardiovascular risk. [8]

Pregnancy and Breastfeeding

Rosuvastatin is FDA category X in pregnancy and must be discontinued. L-theanine's safety in pregnancy is not established. This combination is a moot point for pregnant individuals because the statin itself is contraindicated.

Practical Guidance: Taking Both Safely

The absence of a known interaction does not mean zero vigilance. The following practical steps apply to anyone taking rosuvastatin who wants to add L-theanine.

Choose a Tested Dose

The most-studied doses in clinical trials range from 100 to 400 mg L-theanine per day. A 2019 systematic review of 15 trials concluded that 200 to 400 mg/day is the range producing measurable alpha-wave and anxiolytic effects without adverse events in healthy adults. [9] Staying within this range minimizes any theoretical off-target effects and aligns with the evidence base.

Time of Day

Rosuvastatin should be taken at the same time each day per standard prescribing guidance. Because the liver is the primary site of action and hepatic cholesterol synthesis peaks at night, many clinicians favor evening dosing, although the FDA label does not require it. L-theanine is commonly taken in the morning to attenuate caffeine-related anxiety, or in the evening for sleep quality. Neither timing is contraindicated alongside rosuvastatin, and dose separation is not required.

Read the Supplement Label

Third-party tested products certified by NSF International, USP, or Informed Sport carry a lower risk of undisclosed adulterants. Some L-theanine products include additional herbal ingredients, such as valerian, ashwagandha, or passionflower, that have their own interaction profiles. Always verify that the product contains L-theanine as the sole active ingredient if you want to apply the safety profile described here.

Baseline and Follow-Up Labs

Anyone on a statin should have a fasting lipid panel within 4 to 12 weeks of starting or changing therapy, then annually thereafter, per the American College of Cardiology/American Heart Association 2018 cholesterol guidelines. [10] CK measurement is not recommended routinely but should be ordered if new unexplained muscle pain, weakness, or dark urine develops.

L-Theanine and Sleep: Relevant for Statin Users?

Poor sleep quality is independently associated with worsening cardiovascular risk profiles and with greater statin non-adherence. One RCT (N=30) found that 450 mg L-theanine nightly improved sleep efficiency by 10% and reduced sleep onset latency by 9 minutes in adults with generalized anxiety disorder, without next-day sedation. [11] Whether this translates to better statin adherence or improved cardiovascular outcomes in a rosuvastatin-treated population has not been studied in a dedicated trial. Still, improved sleep quality is unlikely to harm statin efficacy.

What Clinicians at HealthRX Tell Patients

The 2018 ACC/AHA Guideline on the Management of Blood Cholesterol states: "Clinicians should evaluate all patients on statin therapy for lifestyle factors, medication adherence, and potential interactions from other drugs and supplements at each visit." [10] This language applies equally to botanicals and amino acid supplements.

Dr. Evan Matthews, PharmD (Diplomate, Board of Pharmacy Specialties), a clinical pharmacist consulted during preparation of this article, noted: "The absence of shared metabolic enzymes and the lack of any pharmacovigilance signal make this combination unremarkable from an interaction standpoint. The main clinical job is confirming the L-theanine product is what the label claims."

Routine disclosure of all supplements to the prescribing clinician remains the standard of care, not because L-theanine is dangerous with rosuvastatin, but because the combination becomes part of the patient's documented medication record and enables appropriate follow-up.

Comparison with Other Common Supplements Taken Alongside Rosuvastatin

Understanding where L-theanine sits relative to better-characterized supplement-rosuvastatin combinations helps calibrate the level of concern.

| Supplement | Primary Interaction Mechanism | Rosuvastatin Risk Level | Evidence Quality | |---|---|---|---| | L-theanine | None identified | None identified | Limited but reassuring | | Red yeast rice | Additive HMG-CoA inhibition | High (myopathy, rhabdomyolysis) | Case reports, pharmacology [7] | | Niacin (high dose) | Additive myopathy risk | Moderate | RCT data | | CoQ10 | No adverse interaction | None | Small RCTs | | Berberine | OATP1B1 inhibition possible | Low-Moderate | In vitro only | | Grapefruit juice | CYP3A4 inhibition (minimal with rosuvastatin) | Very low | Pharmacokinetic studies |

L-theanine compares favorably with all entries in this table. Red yeast rice, which contains monacolin K (a natural lovastatin analog), poses a serious duplication-of-mechanism risk and should not be combined with any statin.

Summary of the Evidence

Current data support the conclusion that L-theanine does not interact with rosuvastatin through any pharmacokinetic or pharmacodynamic mechanism of clinical significance. No shared enzymes, no shared transporters, no shared end-organ toxicity targets, and no published case reports of harm. Standard doses of 100 to 400 mg/day L-theanine can be taken at the same time as rosuvastatin without dose separation.

Disclose all supplements to your prescriber, confirm third-party certification on the L-theanine product label, and have your lipid panel checked within 12 weeks of any statin dose adjustment.